Fulcrum Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Fulcrum Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Fulcrum Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Fulcrum Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $166k | 18k | 9.20 |
| 2025-03-31 | $605k | 210k | 2.88 |
| 2024-12-31 | $372k | 79k | 4.70 |
| 2024-09-30 | $668k | 187k | 3.57 |
| 2024-06-30 | $205k | 33k | 6.20 |
| 2024-03-31 | $1.5M | 159k | 9.44 |
| 2023-12-31 | $77k | 11k | 6.75 |
| 2023-09-30 | $48k | 11k | 4.44 |
| 2023-06-30 | $4.3k | 1.3k | 3.30 |
| 2023-03-31 | $430k | 151k | 2.85 |
| 2022-12-31 | $1.3M | 185k | 7.28 |
| 2022-06-30 | $971k | 198k | 4.90 |
| 2022-03-31 | $4.7M | 200k | 23.66 |
| 2021-12-31 | $3.6M | 203k | 17.69 |
| 2021-03-31 | $3.1M | 266k | 11.78 |
| 2020-12-31 | $465k | 40k | 11.68 |
| 2020-09-30 | $41k | 5.3k | 7.69 |
| 2020-06-30 | $87k | 4.8k | 18.30 |
| 2020-03-31 | $253k | 21k | 11.93 |
| 2019-12-31 | $99k | 5.9k | 16.80 |
| 2019-09-30 | $10k | 1.5k | 6.72 |